PEGlated magnetic polymeric liposome anchored with TAT for delivery of drugs across the blood-spinal cord barrier.

Due to the existence of the blood-spinal cord barrier (BSCB), many therapeutic macromolecular agents, such as drugs, protein and gene, cannot pass through this barrier to reach the site of injury, all of which restricts the treatment of spinal cord injuries (SCI). In this study, TAT-conjugated PEGlated Magnetic polymeric liposomes (TAT-PEG-MPLs) formed from PEGlated amphiphilic octadecyl quaternized carboxymethyl chitosan (PEG-OQCMC), cholesterol (Chol), superparamagnetic nanoparticles, and transactivating-transduction protein (TAT), were prepared successfully and evaluated the properties in vitro and in vivo. The result indicated that TAT-PEG-MPLs were spherical in solution, with significantly small mean diameter (83.2 nm) and excellent magnetism (magnetization saturation values of 43.5 emu/g). In vitro experiment, the uptake of PEG-MPLs with TAT by MCF-7 cells was greater than that of the PEG-MPLs without TAT. Most importantly, in vivo experiment, a low MRI signal was observed in the T(2)-weighted images; Histological analysis, Cryo-TEM and flame atomic absorption spectrophotometry revealed that TAT-PEG-MPLs nanoparticles significantly accumulated around the site of the SCI even inside the nerve cells. These nanoparticles may provide a promising carrier to locate to the lesion site, deliver therapeutic macromolecular agents across the BSCB and penetrate into the nerve cells for the treatment of SCI.

[1]  E. Agranov,et al.  Passive or Active Immunization with Myelin Basic Protein Promotes Recovery from Spinal Cord Contusion , 2000, The Journal of Neuroscience.

[2]  Xiaofei Liang,et al.  Synthesis, Structure and Properties of Novel Quaternized Carboxymethyl Chitosan with Drug Loading Capacity , 2008 .

[3]  Christoph Alexiou,et al.  Targeting cancer cells: magnetic nanoparticles as drug carriers , 2006, European Biophysics Journal.

[4]  Catherine C. Berry,et al.  Progress in functionalization of magnetic nanoparticles for applications in biomedicine , 2009 .

[5]  R. Ho,et al.  Trends and developments in liposome drug delivery systems. , 2001, Journal of pharmaceutical sciences.

[6]  W. Pan,et al.  Penetration of neurotrophins and cytokines across the blood-brain/blood-spinal cord barrier. , 1999, Advanced drug delivery reviews.

[7]  J. Westman,et al.  Brain derived neurotrophic factor and insulin like growth factor-1 attenuate upregulation of nitric oxide synthase and cell injury following trauma to the spinal cord , 1998, Amino Acids.

[8]  A. Salvador,et al.  Analytical methodologies for atomic spectrometric determination of metallic oxides in UV sunscreen creams. , 2000, Journal of pharmaceutical and biomedical analysis.

[9]  Jin Chang,et al.  Characterization of novel multifunctional cationic polymeric liposomes formed from octadecyl quaternized carboxymethyl chitosan/cholesterol and drug encapsulation. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[10]  J. Leroux,et al.  Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[11]  D. Luo,et al.  Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. , 2008, Biomaterials.

[12]  Denis Gris,et al.  Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment. , 2005, Journal of neurotrauma.

[13]  R. A. Jain,et al.  The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.

[14]  Jason A Burdick,et al.  Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. , 2002, Biomaterials.

[15]  Chi‐Hwa Wang,et al.  Development of a Cell Transducible RhoA Inhibitor TAT-C3 Transferase and its Encapsulation in Biocompatible Microspheres to Promote Survival and Enhance Regeneration of Severed Neurons , 2007, Pharmaceutical Research.

[16]  M. N. R. Kumar A review of chitin and chitosan applications , 2000 .

[17]  Fred H. Gage,et al.  Neurotrophin-3 and Brain-Derived Neurotrophic Factor Induce Oligodendrocyte Proliferation and Myelination of Regenerating Axons in the Contused Adult Rat Spinal Cord , 1998, The Journal of Neuroscience.

[18]  S. Schwarze,et al.  In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.

[19]  M. Pintilie,et al.  Hypoxia and Hypoxia-Inducible Factor-1 Target Genes in Central Nervous System Radiation Injury , 2004, Clinical Cancer Research.

[20]  L. Motte,et al.  Superparamagnetic nanovector with anti-cancer properties: gamma Fe2O3@Zoledronate. , 2009, International journal of pharmaceutics.

[21]  J. Springer,et al.  Calcineurin-Mediated BAD Dephosphorylation Activates the Caspase-3 Apoptotic Cascade in Traumatic Spinal Cord Injury , 2000, The Journal of Neuroscience.

[22]  J. Nah,et al.  Galactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[23]  T. Kissel,et al.  Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers. , 2005, Biomaterials.